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INTRODUCTION
Years of cardiovascular research focusing predominantly
on males have, unfortunately, added to the impression that
cardiovascular disease (CVD) is basically a male affliction. Yet,
CVD is the leading cause of death among elderly women,
especially postmenopausal women (1-3). Although women
are largely protected from clinical coronary disease before
menopause, they rapidly develop an increased risk thereafter.
A lot of evidence has suggested that hormone replacement
therapy (HRT) may suppress the accelerated atherosclerotic
process (4). The mechanism of estrogen’ s protection from
coronary disease appears to be partly due to the pharmaco-
logical effect of estrogen on lipoprotein levels, but we also
have to consider that estrogen may reduce the risk of coro-
nary disease by directly suppressing platelet function (4, 5).
Many dietary intervention studies have also been restricted
to focusing on changes in lipids and lipoproteins, without
examining indices related to the thrombotic risk, e.g. platelet
aggregation and thromboxane formation (6). The effects of
dietary intervention, with respect to coronary disease, also
need to be considered from two approaches as described by
Hoak and Spector, one concerned with atherosclerosis and
the other with thrombosis (7). These effects of diet are not
surprising because the many nutrients which compose our
diet, such as cholesterol, fatty acids, and antioxidant vitamins
and minerals, have a relationship with coronary disease, with
respect to either blood lipid profiles or thrombotic risks. How-
ever, much less is known about the effects of dietary interven-
tion on thrombosis compared to the effects on blood lipid
profiles. 
Dietary factors considered to have a relationship with throm-
bosis are several fatty acids and antioxidant vitamins. Many
nutritionists, to this day, continue to show interest in the fatty
acids composition of lipids in humans, especially in long-chain
polyunsaturated fatty acids (PUFAs) derivatives. This is due
to the role of PUFAs in maintaining the fluidity and function
of cell membranes and the role of PUFAs as precursors of
eicosanoids (8). Many studies have shown that long-chain
saturated fatty acids (SFAs) accelerate thrombus formation,
whereas PUFAs do not, and the PUFA/SFA (P/S) ratio is an
important determinant of thrombogenicity (9, 10). More-
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The Effect of Dietary Intervention Through the Modification of Fatty
Acids Composition and Antioxidant Vitamin Intake on Plasma TXB2
Level in Korean Postmenopausal Women with Hypercholesterolemia
The purpose of this study was to observe the effects of dietary intervention, through
the modification of dietary fatty acids composition and antioxidant vitamins, on
plasma thromboxane B2 (TXB2) levels in postmenopausal women with hyper-
cholesterolemia. The subjects were treated for 12 weeks with one of three methods:
hormone replacement therapy (HRT group, n=8), dietary intervention (DIET group,
n=8), or HRT combined with dietary intervention (HRT+DIET group, n=8). Changes
in serum phospholipid fatty acids composition, serum peroxides, and plasma TXB2
levels were measured at weeks 0, 4 and 12. The P/S ratio increased and the n-
6/n-3 ratio decreased in the DIET and the HRT+DIET group at week 4 (p<0.05).
The ratio of C20:5/C20:4 in serum phospholipid increased in the DIET (p<0.05)
and the HRT+DIET groups (NS) at week 4. Plasma TXB2 levels decreased in the
DIET (-35%, p<0.05) and the HRT+DIET groups (-18.8%, NS) at week 4. Serum
lipid peroxides levels significantly decreased by 10.5% and 15.2% in the DIET
group at weeks 4 and 12, and by 10.8% in the HRT+DIET group only at week 12
(p<0.05). Dietary intervention may lower thrombotic risks in Korean postmenopausal
women by changing the serum fatty acid composition, serum lipid peroxides levels
and plasma thromboxane B2 levels.
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over, different PUFAs have different effects: n-6 PUFAs are
antiatherogenic, whereas n-3 PUFAs are antithrombogenic.
Such differences have been noted since the study of Green-
land Eskimos (11).
When PUFAs metabolism is studied, antioxidants should
be measured because lipid peroxides, formed by the peroxi-
dation of PUFAs, may be important in the development of
atherosclerosis and thrombosis (12). Oxidized low-density
lipoprotein (LDL) has been found in human atherosclerotic
lesions. It has been demonstrated that oxidized LDL decreases
the secretion of endothelium-derived relaxing factors, resulting
in enhanced platelet adhesion (13, 14). Prostacyclin synthesis
in the arterial endothelium was, in cell cultures, irreversibly
inhibited by lipid peroxides, and intracellular lipid peroxides
concentration was regulated by antioxidant enzymes such as
glutathione peroxidase, superoxide dismutase, and catalase,
and also by antioxidant vitamins such as alpha-tocopherol,
ascorbic acid, and beta-carotene. Thus, theoretically, a defi-
ciency in these antioxidants may lead to reduce prostacyclin
synthesis, which can, in turn, promote platelet aggregability.
Moreover, hypercholesterolemic patients show a higher sus-
ceptibility to LDL oxidation (15) and hyperaggregability
(16, 17).
This small-scale study was done to compare the effects of
dietary intervention, through the modification of both dietary
fatty acids composition and antioxidant vitamins, and hormone
replacement therapy (HRT), alone or in combination, on
serum phospholipid fatty acids composition, on plasma TXB2
levels, and also on serum lipid peroxides levels in Korean post-
menopausal women with hypercholesterolemia.
MATERIALS AND METHODS
Subjects
Thirty-six postmenopausal women, aged 50 to 61 yr, were
recruited from a medical center for women in Seoul, Korea. All
had hypercholesterolemia, defined as LDL cholesterol levels
over 160 mg/dL, determined from the mean of two pre-study
fasting samples of serum. All participants had experienced
spontaneous physiologic menopause, and had not received
any type of anti-platelet drug such as nonsteroidal, any anti-
inflammatory agents, or any hormone treatment for at least 6
months before the study. Written, informed consent was
obtained from all subjects, and this study has been performed
in accordance with the principles embodied in the Helsinki
Declaration.
Study design
The subjects were randomly assigned to one of three differ-
ent treatments: hormone replacement therapy (HRT group,
n=8), dietary intervention (DIET group, n=8) or hormone
replacement therapy combined with dietary intervention
(HRT+DIET group, n=8). 
The HRT group and the HRT+DIET group both took,
on a monthly cyclic schedule, a combined therapy of estro-
gen and progesterone, in which conjugated equine estrogen
(CEE, Premarin
�) 0.625 mg was prescribed for 30 days, and
medroxy progesterone acetate (MPA, Provera
�) 5 mg was
combined for the first 12 days. A prescription of HRT was
accomplished with office visits at weeks 0 and 4.
The balanced diet, designed on the basis of our previous
studies in Korean postmenopausal women (18, 19), was pro-
vided for the DIET group and also the HRT+DIET group.
The diet was modified in cholesterol, antioxidant vitamins,
and fatty acid composition. The diet contained cholesterol less
than 70 mg/1,000 kcal and antioxidant vitamins over 90%
of the recommended dietary allowance (RDA) for Koreans.
The P/S ratio of dietary fat increased to the upper limit of the
recommended range, 1-1.5, and the n-6/n-3 ratio decreased
to the lower limit of the recommended range, 4-10 (20). The
changes in the P/S and n-6/n-3 ratio of dietary fat were achi-
eved by making up menus with foods low in fat and choles-
terol and high in antioxidant vitamins.
Energy intake was individually tailored to maintain an ideal
body weight, and menus composed of 1,600 kcal, 1,700 kcal
and 1,800 kcal were provided for the subjects (Table 1). Each
diet consisted of a 10-day rotating menu to provide variety
and maintain the acceptability of the diet. Extensive dietary
counseling was given at the beginning of dietary intervention,
and repeated at each subsequent visit. The subjects were given
dietetic scales, measuring cups and spoons, and were also
trained in estimating portion sizes with the use of uniform
food models.
The study period was a total of 12 weeks. All subjects vis-
ited the clinic at weeks 0, 4 and 12 for treatment and blood
sampling. At each visit, with the exception of week 0, all
subjects completed three-day dietary diaries in order to moni-
tor adherence to the treatment. Dietary intake at the baseline
(week 0) was measured using a semi-quantitative food-fre-
quency questionnaire that has been developed and validated
to assess the usual food intake of Korean postmenopausal
women (21, 22). Nutrient intake was calculated by using the
Hanyang diet analysis program. We tried to encourage com-
pliance in the subjects with follow-up telephone counseling
once a week during the study period. 
Blood analysis
At each visit, a sample of venous blood was drawn after an
overnight fast of 12 to 14 hr. Serum estradiol (E2) levels were
assayed by a procedure based on the competitive binding
principles of radioimmunoassay using the Biodata Estradiol
Maia kit (Code 12264). Serum vitamin A and E levels were
determined using high performance liquid chromatography
(HPLC) as described by Bieri et al. (23). Serum  -carotenelevels were determined according to the method used by Kim
(24) and vitamin C levels were determined according to the
method used by Otsuka et al. (25) using HPLC. Serum lipid
peroxides were measured fluorometrically using thiobarbi-
turic acid reaction (26). Thromboxane B2 (TXB2), the stable
hydrolysis product of TXA2, was measured in plasma using
an enzymeimmunoassy system kit (Code RPN 220, Amer-
sham U.K.).
For analyzing fatty acids composition in serum phospho-
lipid, the serum phospholipid was separated using thin-layer
chromatography on silica gel G-60 (Merch, 20×20 cm) after
extracting serum lipid according to the method used by Folch
(27). Methylation of fatty acids was immediately carried out
according to the procedure of Morrison and Smith (28). Fatty
acid methyl esters were quantified using gas chromatography
(Shimadzu GC-17A) utilizing a 30 m wide-bore column
(0.52 mm internal diameter, Supelco-wax). Fatty acids in lipid
fractions were obtained as percent of distribution.
Statistical analysis
All statistical analyses were performed using the statisti-
cal package for social science (SPSS). The data were analyzed
with repeated-measures analysis of variance to determine any
differences between visits and to determine any differences
among the groups at each visit. Where there was a significant
difference (p<0.05), the analysis of variance was followed by
Duncan’ s multiple range test in order to identify differences.
RESULTS
Of the thirty-six subjects who entered the study, 24 com-
pleted the study period. Twelve subjects failed to complete
the study; four subjects did not complete it for personal rea-
sons, two were lost to follow-up, and six had problems fol-
lowing the dietary intervention program. There was no sig-
nificant difference in the general characteristics of the subjects
among the three groups (Table 2).
Serum estradiol (E2) levels significantly increased in the
two groups taking hormone replacement therapy (HRT),
and there were small but significant increases in the serum
estradiol (E2) levels in the DIET group (Fig. 1). There was a
significant difference in the degree of changes in the serum
E2 levels among the groups (p<0.05); serum E2 levels based
on the initial value were significantly higher, at weeks 4 and
12, in the HRT and HRT+DIET groups than in the DIET
group.
Changes in daily mean nutrient intake during the study
period are shown in Table 3. Nutrient intake of the HRT
group did not change, but there were significant changes in
the nutrient intake of both the DIET group and the HRT
+DIET group, at weeks 4 and 12 (p<0.05). Antioxidant
vitamin A and E intake, which was under 75% of the recom-
mended dietary allowance (RDA) for Koreans at the baseline,
increased to over 90% of the RDA. Cholesterol intake de-
creased to less than 70 mg/1,000 kcal. The P/S ratio increased
from less than 1.0 to 1.3 in the DIET group (p<0.05) and
increased to 1.5 in the HRT+DIET group (p<0.05). The ratio
of n-6/n-3 decreased from 6.9 to 3.5-4.0 in the DIET group
(p<0.05) and decreased from 5.9 to 4.0-5.5 in the HRT+
DIET group (NS). According to an analysis of standardized,
quantitative dietary records, the balanced diet actually con-
sumed by the subjects during the study period was close to
the principles for dietary changes specified in the study design,
with substantial differences between the HRT and the dietary
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Energy (kcal) 1595.0±6.1
a 1710.0±7.2
b 1796.9±5.6
c 0.000
% of energy 17.6±0.4 17.5±0.5 17.5±0.4 0.981
from protein
from fat 18.0±0.5 18.0±0.5 17.7±0.5 0.510
from Carbohydrate 63.1±0.3 64.1±0.4 63.0±0.4 0.790
Dietary fiber (g) 28.6±2.1 27.7±1.9 31.8±1.9 0.321
Vitamin A (% RDA) 117.9±13.2 109.6±13.4 115.9±10.4 0.885
Vitamin C (% RDA) 299.9±22.3 283.6±19.0 318.0±28.1 0.588
Vitamin E (% RDA) 95.9±5.2 96.0±4.3 95.8±3.6 0.999
Cholesterol (mg) 81.9±5.1 84.1±5.7 91.3±5.8 0.456
mg/1,000 kcal 51.3±3.2 49.1±3.3 50.9±3.3 0.882
SFA (% of energy) 4.5±0.2 4.4±0.2 4.3±0.1 0.590
MUFA (% of energy) 4.5±0.2 4.4±0.2 4.5±0.2 0.951
PUFA (% of energy) 6.0±0.4 5.9±0.3 6.3±0.3 0.711
n-6 (% of energy) 10.8±0.5 11.0±0.5 11.2±0.5 0.915
n-3 (% of energy) 2.4±0.2 2.5±0.2 2.4±0.2 0.822
P/S 1.3±0.1 1.4±0.1 1.4±0.1 0.524
n-6/n-3 4.7±0.4 4.5±0.4 4.8±0.3 0.873
Nutrients 1,600 kcal 1,700 kcal 1,800 kcal p-value
Table 1. Nutrients composition of menus provided to the DIET
and the HRT+DIET groups
Age (yr) 51.2±1.2 52.0±2.4 52.0±2.0 0.865
Height (cm) 156.1±1.8 156.9±2.6 159.8±2.0 0.512
Weight (kg) 59.0±1.6 61.3±2.9 61.7±0.2 0.600
BMI (kg/m
2) 24.4±0.6 25.8±1.2 25.4±0.8 0.872
FBS (mg/dL) 83.7±2.6 84.5±3.6 86.3±1.8 0.830
TC (mg/dL) 254.2±6.7 252.5±4.0 256.3±8.0 0.936
TG (mg/dL) 111.2±8.0 110.3±11.6 114.0±2.7 0.965
LDL-C (mg/dL) 166.6±7.7 165.2±6.7 165.9±8.6 0.992
HDL-C (mg/dL) 65.4±2.4 65.3±3.6 67.7±5.8 0.889
mean±SEM; p-value by ANOVA; BMI, body mass index; FBS, fasting
blood sugar. TC, total cholesterol; TG, triglyceride; LDL-C, low density
lipoprotein cholesterol; HDL-C, high density lipoprotein cholesterol;
HRT, hormone replacement therapy group; DIET, dietary intervention
group.
Variables HRT DIET HRT+DIET p-value
(n=8) (n=8) (n=8)
Table 2. The general characteristics of the subjects
mean±SE; Values with different alphabets within the same row are sig-
nificantly different among groups at  =0.05 by Duncan’s multiple range
test; p-value by oneway ANOVA. SFA, saturated fatty acids; MUFA,
monounsaturated fatty acids; PUFA, polyunsaturated fatty acids; P/S,
PUFA/SFA; n-6, n-6 fatty acids; n-3, n-3 fatty acids.310 K. Jung, S. Kim, J. Woo, et al.
intervention groups.
The changes in the fatty acids composition of serum phos-
pholipid (PL) reflected, to some extent, the fatty acid compo-
sition of the modified diet (Table 4). During dietary interven-
tion, the relative % of C14:0, C16:0 and C18:0 decreased,
whereas C18:1, C18:2 (significant only in the HRT+DIET
group), C20:4, C20:5 and C22:6 elevated, at week 4 (p<0.05)
and, to a lower extent, at week 12 in the DIET and the HRT
+DIET groups. With these changes in individual fatty acids
composition, the P/S ratio increased and the n-6/n-3 ratio
decreased at week 4 (p<0.05), but both tended to return to the
initial values at week 12 after dietary intervention. The ratio
of C20:5/C20:4 in serum PL did not significantly change in
the HRT group but elevated in the DIET group (p<0.05) and
HRT+DIET group (NS) at week 4 (Fig. 2). 
The changes in plasma TXB2 levels are shown in Fig. 3. In
the HRT group, plasma TXB2 levels changed from 36.33
±3.49 pg/mL to 36.17±2.40 pg/mL at week 4, and to
39.33±9.66 pg/mL at week 12, but this change was not
statistically significant. In the DIET group, at week 4, TXB2
levels had decreased from 35.00±8.57 pg/mL to 23.10±
3.74 pg/mL (-35.0%, p<0.05). In the HRT+DIET group,
at week 4, TXB2 levels had decreased from 28.79±3.91
pg/mL to 23.40±5.33 pg/mL (-18.8%, NS). Thus, at week
Energy (kcal) 2,053.8±108.6 11,957.5±69.0 2,013.2±103.2 2,052.4±136.8 1,724.4±50.4
� 1,772.4±26.7
� 2,043.1±139.9 1,747.2±38.9
�1,811.9±6.8
�
% of energy
from protein 15.4±0.7 17.1±0.7 16.5±1.0 15.7±1.0 18.2±0.4
� 18.1± 0.6
� 16.8±0.9 17.3±1.2 18.2±0.7
from fat 24.3±1.0 23.0±1.2 23.9±1.2 23.1±0.6 17.1±0.
� 17.7±0.5
� 24.1±2.2 18.0±0.6
� 17.9±0.6
�
from carbohydrate 58.6±1.1 57.5±1.5 57.4±0.9 59.5±1.4 63.5±0.7
� 63.8±0.9
� 56.5±2.6 63.5±1.2
� 62.5±1.1
�
Dietary fiber (g) 22.3±3.9 21.9±2.1 22.0±3.9 25.0±5.4 30.6±4.6 27.1±1.0 22.3±4.8 27.9±0.3 33.7±5.1
Vitamin A (% RDA) 55.3±7.1 54.7±7.9 47.0±6.2 62.5±8.3 103.7±8.9
� 94.6±11.3
� 50.3±8.4 95.4±13.6
� 102.5±18.3
�
Vitamin C (% RDA) 205.5±14.5 185.6±26.7 186.1±51.2 216.1±19.1 257.5±39.7
� 288.6±28.6
� 194.1±13.9 281.5±23.2
� 274.7±50.2
�
Vitamin E (% RDA) 67.9±3.7 68.7±1.7 67.6±3.1 69.6±3.7 96.5±7.4
� 102.5±1.8
� 71.3±5.1 101.5±2.1
� 98.4±4.6
�
Cholesterol (mg) 213.7±18.0 208.6±11.6 212.0±18.6 226.9±18.8 92.1±8.
� 87.5±8.5
� 233.8±9.0 73.8±12.0
� 91.1±7.4
�
mg/1,000 kcal 104.2±7.6 106.7±5.5 105.1±7.1 109.9±9.2 53.7±5.8
� 49.4±5.1
� 115.4±8.0 42.0±6.0
� 50.3±4.2
�
SFA (% of energy) 6.2±0.4 5.9±0.2 6.2±0.4 6.0±0.4 4.6±0.1
� 4.6±0.1
� 6.1±0.3 4.3±0.3
� 4.6±0.3
�
MUFA (% of energy) 6.5±0.3 6.4± 0.2 6.9±0.3 6.2±0.1 4.9±0.
� 5.1±0.1
� 6.6±0.5 4.3±0.5
� 4.9±0.3
�
PUFA (% of energy) 5.1±0.3 5.2±0.3 4.8±0.3 5.1±0.3 6.0±0.5
� 6.2±0.5
� 5.2±0.5 6.8±0.3
� 6.9±0.1
�
n-6 (% of energy) 4.3±0.3 4.5±0.5 4.0±0.3 4.3±0.3 10.4±1.0
� 10.6±0.9
� 4.6±0.8 11.7±0.9
� 11.7±0.1
�
n-3 (% of energy) 0.6±0.1 0.7±0.1 0.8±0.1 0.7±0.1 2.7±0.3
� 2.9±0.2
� 0.8±0.1 2.5±0.5
� 2.8±0.3
�
P/S 0.9±0.1 0.9±0.0 0.8±0.0 0.9±0.1 1.3±0.1
� 1.3±0.1
� 0.9±0.1 1.6±0.1
� 1.5±0.0
�
n-6/n-3 7.2±1.0 6.8±1.2 5.6±1.0 6.9±1.3 3.9±0.4
� 3.6±0.0
� 5.9±1.0 5.3±0.8 4.2±0.5
Values are mean±SE; 
� Significantly different from the initial value in the same group at p<0.05 by repeated measure design.
0 week   4 week 12 week 0 week 4 week 12 week 0 week 4 week 12 week
HRT DIET HRT+DIET
Nutrients
Table 3. Changes in nutrients intake during the study period
C14:0 0.7±0.04 0.94±0.08 0.66±0.05 0.60±0.03 0.56±0.
� 0.55±0.02
� 0.70±0.04 0.64±0.
� 0.60±0.01
C16:0 49.09 ±1.30 55.67±2.26 50.99±1.45 53.02±1.94 46.60±0.
� 50.78±1.11 54.26±0.68 47.04v0.78
� 50.02v1.16
C18:0 22.87±0.51 22.87±0.93 21.26±0.32 25.77±0.55 22.66±0.48
� 23.69±0.49
� 25.04±0.25 20.09±0.73
� 21.89±0.90
�
C18:1 6.71±0.67 5.14±0.90 7.15±0.48 3.92±0.51 7.71±0.16
� 6.96±0.47
� 3.90±0.30 7.56±0.35
� 4.66±0.14
C18:2 (n-6) 14.71±0.90 11.76±1.02 14.77±1.52 12.38±1.27 15.67±0.32 12.90±0.87 11.92±1.00 16.41±0.27
� 14.72±0.66
�
C18:3 (n-3) 0.25±0.04 0.23±0.05 0.27±0.05 0.27±0.02 0.26±0.01 0.29±0.06 0.32±0.06 0.30±0.08 0.17±0.03
C20:4 (n-6) 3.83±0.45 2.34±0.61 3.15±0.63 2.51±0.06 3.12±0.
� 3.59±0.05
� 2.24±0.23 4.24±0.68
� 4.99±0.63
�
C20:5 (n-3) 0.44±0.07 0.20±0.03 0.28±0.08 0.42±0.03 0.61±0.02
� 0.36±0.29
� 0.39±0.07 1.04±0.03
� 0.53±0.09
C22:6 (n-3) 1.41±0.04 0.86±0.29 1.48±0.40 1.11±0.16 2.44±0.12
� 1.35±0.06 1.22±0.08 2.70±0.06
� 2.43±0.33
�
SFA 72.66±1.01 79.48±2.24 72.91±1.70 79.39±1.95 69.82±0.38
� 75.02±1.13
� 80.00±0.77 67.76±1.01
� 72.50±0.28
�
MUFA 6.71±0.67 5.14±0.90 7.15±0.48 3.92±0.51 7.71±0.16
� 6.96±0.47
� 3.90±0.30 7.56±0.35
� 4.66±0.14
PUFA 20.64±0.97 15.39±1.62 19.95±2.09 16.69±1.45 22.47±0.24
� 18.02±1.16 16.09±0.90 24.68±0.69
� 22.84±0.34
�
n-6 18.54±0.91 14.09±1.40 17.92±1.84 14.89±1.32 19.26±0.31
� 16.02±1.06 14.16±0.78 20.65±0.58
� 19.70±0.07
�
n-3 2.10±0.13 1.29±0.31 2.03±0.49 1.80±0.19 3.21±0.14
� 2.00±0.13 1.93±0.14 4.03±0.11
� 3.13±0.41
P/S 0.29±0.02 0.20±0.03 0.28±0.03 0.21±0.02 0.32±0.01
� 0.24±0.02 0.20±0.01 0.37±0.02
� 0.32±0.06
�
n-6/n-3 8.94±0.58 12.69±1.72 11.44±2.21 8.81±0.90 6.10±0.32
� 8.07±0.37 7.40±0.29 5.12±0.05
� 7.07±1.19
Values are mean±SE; 
� Significantly different from the initial value in the same group at p<0.05 by repeated measure design.
0 week   4 week 12 week 0 week 4 week 12 week 0 week 4 week 12 week
HRT DIET HRT+DIET
Fatty acids
Table 4. Changes in fatty acids composition in serum phospholipid during the study period
Relative % of total fatty acids Effect of Dietary Intervention on Plasma TXB2 Levels 311
4, differences due to treatment were observed; plasma TXB2
levels were lower in both the DIET group and the HRT+
DIET group than in the HRT group (p<0.05). However,
TXB2 levels in the DIET and the HRT+DIET groups re-
turned to initial levels at week 12.
The changes in serum antioxidant are shown in Table 5. In
the DIET group, serum vitamin A levels increased by 10.9%
at week 4 and increased by 27.3% at week 12 (p<0.05). In
the HRT+DIET group, serum vitamin A level increased
by 11.9% only at week 12 (p<0.05). In the HRT+DIET
group, serum  -carotene levels increased by 3.6% at week 4
and increased by 5.2% at week 12, whereas in the DIET group,
the serum vitamin E level increased by 14.3% at week 4 and
increased by 22.7% at week 12 (p<0.05). As for serum vita-
min E levels, at week 12, a difference due to treatment was
also observed; serum vitamin E levels were higher in both
the DIET group and the HRT+DIET group than in the HRT
group (p<0.05). Serum vitamin C, which, at the beginning
of this study, was ingested at a level higher than the RDA,
did not significantly change throughout the study period.
With changes in serum antioxidant vitamin A, vitamin E,
and  -carotene levels, the serum MDA levels in the DIET
group significantly decreased by 10.5% at week 4 and de-
creased by 15.2% at week 12 (p<0.05). In the HRT+DIET
group, the serum MDA levels decreased by 10.8% only at
week 12 (p<0.05) (Fig. 4).
DISCUSSION 
It is well established that Greenland Eskimos have a low
incidence of cardiovascular disorders and they also have a bleed-
ing tendency that may result from reduced platelet aggrega-
tion. It has been shown that their intake of n-3 fatty acid, C20:5
is high and, conversely, their intake of n-6 fatty acids, C18:2
and C20:4 is low. Also, both their plasma and platelet lipids
have a similar fatty acid pattern to that found in their diet (29).
Therefore, it has been suggested that a shift in dietary fatty
acids composition towards the Greenland Eskimo pattern may
prevent certain cardiovascular disorders, especially by reducing
Vitamin A ( g/mL) 0.55±0.03 0.58±0.02 0.57±0.04 0.55±0.05 0.61±0.07
� 0.70±0.10
� 0.59±0.03 0.70±0.12 0.66±0.03
�
-Carotene ( g/dL) 22.83±3.22 20.60±2.33 20.76±1.86 20.81±2.15 21.49±2.61 22.86±2.05 21.25±1.15 22.35±0.85
� 22.01±0.80
�
Vitamin C ( g/mL) 11.58±0.34 11.10±0.59 11.02±0.61 12.11±0.35 13.13±0.31 11.91±0.77 12.31±0.60 12.78±0.75 12.11±0.98
Vitamin E ( g/mL) 9.66±0.17 9.51±0.22 9.42±0.30a 9.10±0.46 10.40±0.67
� 11.17±0.27 b� 9.19±0.61 8.71±0.48 10.43±0.28c
Values are mean±SE; 
� Significantly different from the initial value in the same group at p<0.05 by repeated measure design; Values with different alpha-
bets within the same week are significantly different among groups based on the initial value at p<0.05 as analyzed by repeated measure design.
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� , significantly different from the initial value in the same group at
p<0.05 by a repeated measure design.
�the risk of thrombosis (30).
In the present study, at week 4, with the changes in the
dietary fat composition after the dietary fat modification, serum
phospholipid (PL) P/S ratios increased by 52.4% in the DIET
group, and increased by 85.0% in the HRT+DIET group
(p<0.05). Also at week 4, n-6/n-3 ratios decreased by 30.7% in
the DIET group and decreased by 30.8% in the HRT+DIET
group (p<0.05). Despite the fact that fatty acid changes in
dietary fat in the two groups were maintained until week 12,
ratios in serum PL tended to return to their initial values at
week 12. The reason for this finding remains uncertain, but in
some cases, poor responses can be explained by poor adherence
to diet. Many studies have indicated that changes in fatty acids
of dietary fat led to changes in fatty acids of serum and cell
lipids, and, consequently, said studies pointed out the impor-
tance of dietary habits on the blood fatty acids composition
(30-32). Therefore, we can suppose that the subjects of the
HRT group and the HRT+DIET group may have progres-
sively departed from the prescribed balanced diet, but failed
to report these behavioral changes in their dietary diaries. On
the other hand, in the HRT group, a few fatty acids of serum
PL also changed, even though there were no significant changes
in their fatty acid intakes. Several studies have suggested that
estrogen can affect blood fatty acid composition, but we can-
not conclude whether those changes are due to estrogen, or
not (33, 34). Even now, the effect of estrogen on serum fatty
acid composition is controversial, and, as such, requires fur-
ther research.
Platelet aggregation is modulated by the production of TXA2
and PGI2. An optimal balance of TXA2-PGI2 may be impor-
tant in the prevention of thrombotic conditions. Evidence indi-
cates that dietary fatty acids can alter this balance (35, 36).
According to Kinsella et al. (35), the only dietary fatty acid
change shown to affect thrombosis in humans is an increased
intake of n-3 fatty acids. When this occurs, the platelets accu-
mulate n-3 fatty acids, especially eicosapentaenoic acid. The
n-3 fatty acids replace some of the arachidonic acid in the
platelet membranes, decreasing its availability for eicosanoid
formation. As a result, less TXA2 is produced in response to
activation, and the tendency for the platelets to aggregate is
reduced (30, 38). In this present study, at week 4, the ratios
of C20:5/C20:4 in serum PL increased, but plasma TXB2
levels, metabolites of TXA2 (39), decreased by 35.0% in the
DIET group (p<0.05) and decreased by 18.8% in the HRT
+DIET group (NS). Recently, Mantzioris et al. reported that
an increase of dietary C20:5 intake led to an average 3-fold
increase in C20:5 in plasma, platelet, and mononuclear cell
phospholipids, and they also reported TXB2 synthesis decreased
by 36% (39). These findings, taken in conjunction with pre-
vious epidemiological studies in Eskimos, suggest that a change
in fatty acids consumption, such that a diet with a high C20:
5/C20:4 ratio could reduce platelet aggregability by decreas-
ing plasma TXB2 levels, would exert a beneficial influence on
certain cardiovascular disorders.
Many studies have suggested that oxidative modification of
low-density lipoprotein (LDL) promotes atherosclerosis, which,
in turn, has brought about considerable interest in the role of
dietary antioxidant vitamins in preventing CVD (40-42).
When PUFAs metabolism is studied, antioxidants should be
measured because lipid peroxides, formed by the peroxidation
of PUFAs, may be important in the development of atheroscle-
rosis and thrombosis (12, 43, 44). It has also been suggested
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b 
�athat oxidized LDL may enhance the progression of atheroscle-
rotic lesions by increasing platelet adhesion and aggregation,
triggering thrombosis and impairing vasodilatation (45).
Living organisms have two principal means of protecting
themselves from the potentially injurious effects of free radi-
cals. One means of protection involves enzymes such as glu-
tathion peroxidase and catalase, both of which contain specif-
ic trace elements (selenium, copper, manganese, and zinc). The
other means of protection involves antioxidants, especially
vitamin C and E, and carotenoids. Vitamin C,  -tocopherol,
and  -carotene are among the most abundant dietary antiox-
idants, and the concentration of these antioxidants is mainly
determined by their dietary supply (46). The role of dietary
antioxidant vitamins in preventing CVD can be of greater
importance in postmenopausal women because serum lipid
peroxides levels in postmenopausal women are higher than
serum lipid peroxides levels in premenopausal women (47). 
In this present study, there was a significant reduction in
serum MDA levels in the DIET group and in the HRT+
DIET group, despite an increase of P/S ratios in the dietary
fat and serum PL of the two groups. This reduction in serum
MDA levels is considered to be due to the increase in the two
groups’ serum vitamin A,  -carotene, and especially vitamin
E levels, through the modification of these aforementioned
dietary antioxidant vitamins. Clinical trials suggest that vita-
min E reduces platelet aggregability, and trials also suggest
that there is a strong association between low serum vitamin
E levels and platelet aggregability. These results indicate that
antioxidants may be important in the regulation of platelet
function (48, 49). Salonen et al. have reported that antioxi-
dant supplementation in men with low a antioxidant status
and a high fat intake reduces lipid peroxidation, reduces the
capacity of platelets to aggregate and to produce TXA2, and
also reduces in vivo platelet activation (49). The reduction in
plasma TXB2 levels may be related to the observed reduc-
tion of serum MDA levels in both the DIET group and the
HRT+DIET group (week 4), taking into account the results
of these studies (48-49). In fact, there was a significant corre-
lation between the serum MDA levels and the plasma TXB2
levels in the DIET group and the HRT+DIET group ( =
0.684, p=0.007, data not shown). However, previous clinical
trials on the effects of antioxidants on platelet function have
produced inconsistent results. Recently, epidemiological and
clinical trial data suggested the absence of relevant clinical
effects of antioxidant vitamins on the risk of cardiovascular
events (50). Thus, the relationship between serum antioxidant
vitamins, MDA levels, and platelet function needs further
research.
We do not know whether the reduction in the plasma TXB2
level observed in our study was due to changes in serum PL
fatty acid composition or changes in the serum MDA levels.
The relationship between fatty acid composition, antioxidant
vitamins, serum MDA levels, and platelet function needs fur-
ther research. However, more importantly, the focus in this
present study is on ‘what diet is good’ rather than ‘what nutrient
is good’ for the prevention of cardiovascular disease. The
dietary modifications needed to prevent certain diseases may
probably be much larger than those usually occurring in the
human diet, making it unlikely that these processes would
come into play under ordinary conditions. In fact, this study
devoted considerable effort to encourage dietary compliance,
which is not easy in routine clinical practice. Nevertheless, it
is very stimulating to note that postmenopausal women, if
they are highly motivated, can decrease their thrombotic risks
by way of dietary intervention which can be achieved by replac-
ing SFAs with PUFAs, eating less fat- and cholesterol-rich
foods, eating more fish and lean meat, and eating more fresh
fruits and vegetables.
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